Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like we're stuck here in the .003's...hey at least it's predictable and you can't lose sleep over it lol. I got mine tucked away, I will be here when that time comes. Real stuff always takes time. Good luck to us all.
They have a good following and from wha I can see on profit.ly some good trading history, you a member there? Recommendations?
This was my first time playing BDPS promo, I must say...not too impressed. APS is by far my favorite...have been playing them a while, always make good money there without having to worry about disaster for at least a week or two. I made $900 of this today, but I think folks are weary here after what happened to POWT...good luck to all who's still flipping this.
The low float in this one is enough to drive it nuts, let's hope for the best
Don't know about y'all but I'd be very happy to see $1, let alone a couple of bucks. I hope it runs strong the rest of the week, expecting a strong day tomorrow.
We will see you tomorrow partner..let's see how many times you're gonna be wrong before you get embarrassed enough to stop posting here. Half million promo, do you know what that means? At least going to .80... Mark it, learn it, and make money from it brah!
This should hold just fine because most of the day it has been trading sideways, so not a lot of profit taking opportunity. Should gad up and continue run tomorrow and into Friday. I see .70+ on Friday with profit taking end of day. With a half mil promo, this will be around a while. Just getting started imo. APS's NSRS was a half mil promo as well, and we know where that went.
I see at least .80 range here. With a small float like this, $1 isn't hard to get to...it's only Tuesday!
Damn this was hard to get into...had some chasing going on!
We've got some players showing up on the board, this is a good sign. ICPA will reward us for our patience.
Correct me if I'm wrong but weren't you the one saying that you were going to buy this in the .20's?
Good day today, should see .20's tomorrow...this thing is a traders dream. Loving the momo.
Some exciting stuff brewing...this stock is trading perfectly...sideways action until we explode!
Have been away from this board a bit, what is the latest on the Spyder, wasn't that due to be effective soon?
Did you add that 'our next pick is based on stem cell technology' nonsense yourself? The email I got said nothing of the sort.
Gonna add some more to my position by Friday, if not tomorrow...the only place this is going is up. Really curios about what fuse is lit and the dynamite that is about to blow
What is with the same old people that have nothing but negative things to say...if it was up to you, markets would crash everyday. If you don't like being attacked, then don't go around bashing everything in sight...relax, I've been doing this a while. I'm not going to post something that I do not believe has the potential to make people profits here. Why don't you try the same and recommend something useful, instead of wasting keystrokes and everybody's time?
You know, for some reason all I've ever seen you do is say something is going down...let me see, you were bashing PEIX when it was trading around .50, look at you now...I wouldn't follow your advice if you gave me the money to trade. Let's watch what happens together as I school you in trading!
Spam? This is going to $5 buddy, don't you ever get sick of being negative? Because I get sick of people like you easily!
ALIM - HUGE NEWS!
7 Mil Float!!!
pSivida Corp. Announces Positive Outcome to European Decentralized Procedure for Approval of ILUVIEN(R) for the Treatment of Chronic Diabetic Macular Edema
6:36 AM ET 2/28/12 | BusinessWire
--ILUVIEN expected to be indicated for chronic DME considered insufficiently responsive to available therapies
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the positive outcome of the Decentralized Procedure (DCP) for the approval of ILUVIEN(R) in Europe. The announcement follows the issuance of the Final Assessment Report to pSivida's licensee Alimera Sciences, Inc. from the Reference Member State (RMS), the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA), and the agreement of all the Concerned Member States (CMS) that ILUVIEN is approvable.
The regulatory process will now enter the national phase of the DCP in which the RMS and each CMS grants its national license. The CMS include Austria, France, Germany, Italy, Portugal and Spain. ILUVIEN will be indicated for the treatment of vision impairment associated with chronic DME considered insufficiently responsive to available therapies.
The International Diabetes Federation estimates that, in these seven countries alone, 22.1 million people are currently living with diabetes. By comparison, the Centers for Disease Control and Prevention estimate that Americans with diabetes now number 25.8 million. Alimera estimates that within the seven CMS countries, 1.2 million people suffer from DME.
"I'm very pleased about this favorable outcome of the EU regulatory process for ILUVIEN," said Paul Ashton, president and chief executive officer of pSivida.
ILUVIEN is an injectable, sustained-release intravitreal insert that releases sub-microgram levels of fluocinolone acetonide (FAc) for up to 36 months for the treatment of chronic DME. pSivida is developing an insert of the same design for the treatment of uveitis affecting the posterior of the eye.
About pSivida Corp.
pSivida Corp., headquartered in Watertown, MA, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. pSivida is currently focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, Durasert(TM) and BioSilicon(TM). ILUVIEN(R) for the treatment of Diabetic Macular Edema (DME), which is licensed to Alimera Sciences, Inc., is pSivida's most advanced product candidate, and based on a consensus arrived upon by the RMS and the CMS, the MHRA issued its Final Assessment Report that ILUVIEN for chronic DME is approvable. An investigator-sponsored Investigational New Drug application opened for an injectable insert to treat posterior uveitis of the same design as ILUVIEN for DME, and an investigator-sponsored trial is ongoing for an injectable, bioerodible insert to treat glaucoma and ocular hypertension. pSivida's two FDA-approved products, Retisert(R) and Vitrasert(R), are implants that provide long-term, sustained drug delivery to treat two other chronic diseases of the retina.
SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: Various statements made in this release are forward-looking, and are inherently subject to risks, uncertainties and potentially inaccurate assumptions. All statements that address activities, events or developments that we intend, expect or believe may occur in the future are forward-looking statements. The following are some of the factors that could cause actual results to differ materially from the anticipated results or other expectations expressed, anticipated or implied in our forward-looking statements: Alimera's ability to successfully obtain regulatory approval of and commercialize ILUVIEN for DME in the EU; actions with respect to regulatory approval of ILUVIEN for DME in the U.S.; ability to obtain additional capital; ability to attain profitability; adverse side effects; exercise by Pfizer of the Latanoprost Product option; ability to complete clinical trials and obtain regulatory approval of product candidates; further impairment of intangible assets; fluctuations in operating results; decline in royalty revenues; ability to find partners to develop and market products; termination of license agreements; competition; market acceptance of products and product candidates; reduction in use of products as a result of future guidelines, recommendations or studies; ability to protect intellectual property and avoid infringement of others' intellectual property; retention of key personnel; product liability; consolidation in the pharmaceutical and biotechnology industries; compliance with environmental laws; manufacturing risks; risks and costs of international business operations; credit and financial market conditions; legislative or regulatory changes; volatility of stock price; possible dilution; possible influence by Pfizer; ability to pay any registration penalties; absence of dividends; and other factors described in our filings with the Securities and Exchange Commission. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Our forward-looking statements speak only as of the dates on which they are made. We do not undertake any obligation to publicly update or revise our forward-looking statements even if experience or future changes makes it clear that any projected results expressed or implied in such statements will not be realized.
SOURCE: pSivida Corp.
Good lord 200k...what kind of dough y'all folks playing with, thought I was balling with 10% that lol
Hey man after all that money you made with the train you're still hunting for a buck? Lol...yeah I've been in this one a short while, lots of stuff pending here and tight trading range. Once we get some deals announced, we're gonna be hunting for spots to spend our bucks
Mind indulging in more details about this, I'm all ears for static!
Looks like the radio interview is what this stock needs for a good run. Losing a little steam here.
Got my eye on this for mañana, let's make some money shall we?
So far this year ATRN has made a good run after a few days of sideways trading. Looking into getting a new position here this week. I will be watching closely and get in on a good dip opportunity. ATRN has been good to me, I will come back to her shortly :)
Wtf? Is the market a little slow? What about these numbers did the market not like? Make no sense...glad my last minute buy order didn't go through now lol.
So who's betting this goes up after hours...I'm thinking good numbers are going to come out.
Why has this been blowing up lately, whats the dillio?
Looks like a green day here.
So when is the rescheduled interview?
Yeah glad you missed it now C,mon how am I supposed to believe these guys were bunch of amateur morons? I mean this isn't exactly their first rodeo...It was announced just like NSRS was. You got lucky on this one
Just got the email...not chasing something already up 300% lol...these alerts need to come when its up 15-25%. Good luck to all!
Well this is not at all what I had hoped for with their pick...Their reputation is all over the floor now...what kind of amateur move is this when you're talking about millions of dollars? Really, send the alerts and wait until the next morning to try and say it was a mistake...may as well go with it once you let the cat out of the bag.
Now, we don't know whether to buy or steer clear...it's a crapshoot if you ask me...and I'm not about to put money on a crapshoot. May as well go to Vegas and play blackjack!
Would you believe it...I had to dig my spam folder to find APS and 3 sister sites alert on this? I've been getting emails from these guys for months, are you kidding me?
Oh well, at leas I know the show is on!
If you think this goes anywhere below a dollar tomorrow il bet you $100 right here on this board? Care to put your money where your mouth is?
Lol yeah y'all been saying that on every one of the pumps...I'll send you my regards with a postcard purchased via my APS winnings :)
This stock will not touch a dollar tomorrow...I expect $1.35-$2.12 trading range.
Did anyone actually get an email from APS itself? I got one from PSU and no one else...I know they're part of the group but don't they usually send their stuff around the same time...I have gotten all their mails within an our of each other and they're all the same....thats the only odd thing I see here...hmmm.
I'm putting in a cool 10k on this tomorrow...and getting out once I make 10k...badabbababaaaaa......I'm loving' it!
Well hot dang! I was at work, came home took a nap and these suckers sent the email during all of that...I've been waiting for this play too. Looks like I'm not in on the first da but you can bet your bottom I'll be in tomorrow and sell when it hits $3. Which should be next week lol.